This is an outdated version published on 2020-04-13. Read the most recent version.

Antibodies and protection against COVID-19

Authors

  • Constantino López-Macías <p>Instituto Mexicano del Seguro Social, Hospital de Especialidades &ldquo;Dr. Bernardo Sep&uacute;lveda Guti&eacute;rrez&rdquo;, Unidad de Investigaci&oacute;n M&eacute;dica en Inmunoqu&iacute;mica. Ciudad de M&eacute;xico&nbsp;</p>
  • Tania Rivera-Hernández <p>Instituto Mexicano del Seguro Social, Hospital de Especialidades &ldquo;Dr. Bernardo Sep&uacute;lveda Guti&eacute;rrez&rdquo;, Unidad de Investigaci&oacute;n M&eacute;dica en Inmunoqu&iacute;mica. Ciudad de M&eacute;xico</p>

DOI:

https://doi.org/10.24875/RMIMSS.M20000001

Keywords:

SARS Virus, Coronavirus Infections, Antibodies, Virus Diseases

Abstract

Antibodies are one of the most important components of the immune system against infections. So far, little is known about the contribution of antibodies in the protection against the SARS-CoV-2. Measuring antibody levels in the population will allow to determine who has been infected; this could also be useful to know if people with certain levels of antibodies are already protected against the disease.

Downloads

Download data is not yet available.

References

Amanat F, Stadlbauer D, Strohmeier S, Nguyen T, Chromikova V, McMahon M, et al. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. 2020;26:1033-6. doi:https://doi.org/10.1038/s41591-020-0913-5

 

To KKW, Tsang OTY, Leung WS, Tam AR, Wu TC, Lung DC, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2:an observational cohort study. Lancet Infect Dis. 2020;20(5):565-74. doi:10.1016/S1473-3099(20)30196-1

 

Callaway E. Coronavirus vaccines:five key questions as trials begin. Nature. 2020;579(7800):481. doi:10.1038/d41586-020-00798-8

Downloads

Published

2020-04-13

Versions

Issue

Vol. 58 No. 2 (2020): March-April

Section

Editorial

License

Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.